American Alpha Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
American Alpha Advisors's BMY Position: Q1 2026 in Review
American Alpha Advisors increased its Bristol-Myers Squibb (BMY) stake by 3.4% in Q1 2026, buying an estimated $21.8K and bringing the position to 11,268 shares worth $683K. The position accounts for 0.36% of the portfolio, ranked #46.
American Alpha Advisors first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- American Alpha Advisors held 11,268 shares of Bristol-Myers Squibb worth $683K as of Q1 2026.
- American Alpha Advisors bought 374 Bristol-Myers Squibb shares in Q1 2026, an estimated $21.8K.
- Bristol-Myers Squibb made up 0.36% of American Alpha Advisors's portfolio in Q1 2026, its #46 holding.
- American Alpha Advisors first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on American Alpha Advisors's 13F filing for Q1 2026, filed 15 May 2026.